🇺🇸 FDA
Pipeline program

Cipaglucosidase Alfa

ATB200-03

Phase 3 mab completed

Quick answer

Cipaglucosidase Alfa for Pompe Disease (Late-onset) is a Phase 3 program (mab) at AMICUS THERAPEUTICS PTY LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
AMICUS THERAPEUTICS PTY LTD
Indication
Pompe Disease (Late-onset)
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials